
Organon & Co. – NYSE:OGN
Organon & stock price today
Organon & stock price monthly change
Organon & stock price quarterly change
Organon & stock price yearly change
Organon & key metrics
Market Cap | 3.71B |
Enterprise value | 11.86B |
P/E | 2.98 |
EV/Sales | 1.85 |
EV/EBITDA | 7.03 |
Price/Sales | 0.60 |
Price/Book | 7.86 |
PEG ratio | 0.14 |
EPS | 4.11 |
Revenue | 6.34B |
EBITDA | 1.46B |
Income | 1.04B |
Revenue Q/Q | 5.46% |
Revenue Y/Y | 3.28% |
Profit margin | 20.3% |
Oper. margin | 23.44% |
Gross margin | 58.26% |
EBIT margin | 23.44% |
EBITDA margin | 23.08% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrganon & stock price history
Organon & stock forecast
Organon & financial statements
Jun 2023 | 1.60B | 242M | 15.05% |
---|---|---|---|
Sep 2023 | 1.51B | 58M | 3.82% |
Dec 2023 | 1.59B | 546M | 34.17% |
Mar 2024 | 1.62B | 201M | 12.39% |
Mar 2024 | 1.62B | 201M | 12.39% |
---|---|---|---|
Sep 2025 | 1.52B | 268.13M | 17.58% |
Oct 2025 | 1.55B | 271.28M | 17.42% |
Dec 2025 | 1.59B | 269.29M | 16.84% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 22.75% |
---|
2019 | |
---|---|
2020 | |
2021 | 1.88% |
2022 | 4.09% |
2023 | 7.99% |
Jun 2023 | 10979000000 | 11.53B | 105.06% |
---|---|---|---|
Sep 2023 | 11012000000 | 11.60B | 105.35% |
Dec 2023 | 12058000000 | 12.12B | 100.58% |
Mar 2024 | 11891000000 | 11.84B | 99.6% |
Jun 2023 | 27M | -70M | -88M |
---|---|---|---|
Sep 2023 | 261M | -55M | -78M |
Dec 2023 | 397M | -81M | -77M |
Mar 2024 | 76M | -96M | -74M |
Organon & alternative data
Areas of Focus
19 Feb 2023 | 19 | 31 |
---|---|---|
26 Feb 2023 | 33 | 31 |
5 Mar 2023 | 26 | 36 |
12 Mar 2023 | 30 | 34 |
19 Mar 2023 | 34 | 29 |
26 Mar 2023 | 34 | 32 |
2 Apr 2023 | 32 | 43 |
9 Apr 2023 | 28 | 28 |
16 Apr 2023 | 24 | 35 |
23 Apr 2023 | 27 | 40 |
30 Apr 2023 | 29 | 46 |
7 May 2023 | 22 | 29 |
14 May 2023 | 33 | 38 |
21 May 2023 | 28 | 30 |
28 May 2023 | 20 | 36 |
4 Jun 2023 | 24 | 35 |
11 Jun 2023 | 25 | 31 |
18 Jun 2023 | 20 | 30 |
25 Jun 2023 | 12 | 15 |
2 Jul 2023 | 19 | 17 |
Organon Biosimilars Products
19 Feb 2023 | 27 | 42 | 0 |
---|---|---|---|
26 Feb 2023 | 8 | 55 | 0 |
5 Mar 2023 | 16 | 50 | 0 |
12 Mar 2023 | 12 | 71 | 0 |
19 Mar 2023 | 16 | 61 | 0 |
26 Mar 2023 | 12 | 50 | 0 |
2 Apr 2023 | 0 | 35 | 0 |
9 Apr 2023 | 15 | 60 | 0 |
16 Apr 2023 | 8 | 53 | 27 |
23 Apr 2023 | 46 | 53 | 0 |
30 Apr 2023 | 0 | 77 | 0 |
7 May 2023 | 11 | 45 | 0 |
14 May 2023 | 0 | 49 | 8 |
21 May 2023 | 17 | 49 | 0 |
28 May 2023 | 12 | 55 | 0 |
4 Jun 2023 | 13 | 62 | 18 |
11 Jun 2023 | 20 | 52 | 9 |
18 Jun 2023 | 0 | 40 | 0 |
25 Jun 2023 | 25 | 24 | 25 |
2 Jul 2023 | 0 | 62 | 0 |
Organon Oncology Products
12 Feb 2023 | 32 | 0 |
---|---|---|
19 Feb 2023 | 0 | 0 |
26 Feb 2023 | 0 | 0 |
5 Mar 2023 | 0 | 20 |
12 Mar 2023 | 0 | 15 |
19 Mar 2023 | 19 | 0 |
26 Mar 2023 | 0 | 0 |
2 Apr 2023 | 0 | 0 |
9 Apr 2023 | 0 | 0 |
16 Apr 2023 | 0 | 0 |
23 Apr 2023 | 0 | 0 |
30 Apr 2023 | 0 | 0 |
7 May 2023 | 0 | 22 |
14 May 2023 | 0 | 0 |
21 May 2023 | 16 | 16 |
28 May 2023 | 0 | 0 |
4 Jun 2023 | 14 | 0 |
11 Jun 2023 | 19 | 0 |
18 Jun 2023 | 0 | 35 |
25 Jun 2023 | 42 | 0 |
Organon Women's Health Products
26 Feb 2023 | 56 | 0 |
---|---|---|
5 Mar 2023 | 53 | 0 |
12 Mar 2023 | 47 | 0 |
19 Mar 2023 | 52 | 0 |
26 Mar 2023 | 46 | 0 |
2 Apr 2023 | 51 | 0 |
9 Apr 2023 | 52 | 0 |
16 Apr 2023 | 46 | 0 |
23 Apr 2023 | 47 | 0 |
30 Apr 2023 | 50 | 0 |
7 May 2023 | 56 | 0 |
14 May 2023 | 46 | 0 |
21 May 2023 | 50 | 0 |
28 May 2023 | 48 | 0 |
4 Jun 2023 | 57 | 0 |
11 Jun 2023 | 53 | 0 |
18 Jun 2023 | 56 | 0 |
25 Jun 2023 | 45 | 0 |
2 Jul 2023 | 42 | 0 |
9 Jul 2023 | 41 | 0 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
Sep 2023 | 146 |
---|---|
Oct 2023 | 119 |
Nov 2023 | 117 |
Dec 2023 | 154 |
Jan 2025 | 163 |
Feb 2025 | 102 |
May 2025 | 148 |
Jul 2025 | 170 |
Sep 2023 | 10,000 |
---|---|
Oct 2023 | 10,000 |
Nov 2023 | 10,000 |
Dec 2023 | 10,000 |
Jan 2024 | 10,000 |
Feb 2024 | 10,000 |
Mar 2024 | 10,000 |
Apr 2024 | 10,000 |
May 2024 | 10,000 |
Jun 2024 | 10,000 |
Jul 2024 | 10,000 |
Organon & other data
Period | Buy | Sel |
---|---|---|
Feb 2024 | 2720 | 0 |
Quarter | Transcript |
---|---|
Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 15 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
Organon: A Look Beyond The Dividend Cut
Why Investors Should Watch Teva Despite Regional Risks
Organon & Co: Cost Takeout Catalysts, Initiate Strong Buy
Top 4 Immunology Stocks Poised For Growth In 2025
Four Reasons Why Organon Stock Is A Good Buy
Pfizer: Buy The Panic
8 Tax-Loss Sell Alerts For December
Organon: It's Darkest Before The Dawn
Pfizer: Value Investment Opportunity After Recent Price Decline
-
What's the price of Organon & stock today?
One share of Organon & stock can currently be purchased for approximately $9.28.
-
When is Organon &'s next earnings date?
Unfortunately, Organon &'s (OGN) next earnings date is currently unknown.
-
Does Organon & pay dividends?
Yes, Organon & pays dividends and its trailing 12-month yield is 7.44% with 23% payout ratio. The last Organon & stock dividend of $0.28 was paid on 16 Dec 2021.
-
How much money does Organon & make?
Organon & has a market capitalization of 3.71B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.44% to 6.26B US dollars.
-
What is Organon &'s stock symbol?
Organon & Co. is traded on the NYSE under the ticker symbol "OGN".
-
What is Organon &'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of Organon &?
Shares of Organon & can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Organon & have?
As Jul 2024, Organon & employs 10,000 workers.
-
When Organon & went public?
Organon & Co. is publicly traded company for more then 4 years since IPO on 14 May 2021.
-
What is Organon &'s official website?
The official website for Organon & is organon.com.
-
Where are Organon &'s headquarters?
Organon & is headquartered at 30 Hudson Street, Jersey City, NJ.
-
How can i contact Organon &?
Organon &'s mailing address is 30 Hudson Street, Jersey City, NJ and company can be reached via phone at +55 14306000.
Organon & company profile:

Organon & Co.
organon.comNYSE
10,000
Drug Manufacturers - General
Healthcare
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.
Jersey City, NJ 07302
CIK: 0001821825
ISIN: US68622V1061
CUSIP: 68622V106